Balsat M, Alcazer V, Etienne G, Huguet F, et al. First-line second generation tyrosine kinase inhibitors in patients with newly diagnosed accelerated phase chronic myeloid leukemia. Leuk Res 2023;130:107308.
PMID: 37230027